Further studies have found that the use of FASN drug inhibitors can cause breast cancer cells to undergo apoptosis or tumor cell shrinkage, which indicates that FASN has a protective effect on breast cancer cells [104,105,106]. The gene discussed is FASN; the disease is breast cancer.